As VP of Business Development and Marketing, Katie is well-versed in listening to client challenges and identifying a solution that fits their timeline and budget. Previously, Katie served as Associate Vice President of IU Ventures and retains her role as a board observer at Qumulex, an IU Ventures portfolio company. Prior to that, she managed the protection and commercialization of technology emanating from innovations by academic researchers as Acting Director of the Innovation and Commercialization Office at Indiana University and before joining IU, at the University of Michigan’s Office of Technology Transfer. With her scientific background and experience in IP licensing and early-stage therapeutic development, Katie understands what our clients are facing and how we can best support them.
Why Genezen? During my time in venture capital, I loved working with early-stage companies. I also wanted to focus more on life science therapeutics, and the team at Genezen was a huge draw for me.
My greatest passion: Scientific advancements that truly help patients. I also love camping, podcasts and being a soccer Mom.
Our team is dedicated to getting your viral vector where it needs to go. Communication and collaboration are part of our DNA and we can't wait to talk to you about your current challenges and needs.